Article Details

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of “Moderate Buy ...

Retrieved on: 2025-03-03 07:43:02

Tags for this article:

Click the tags to see associated articles and topics

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of “Moderate Buy .... View article details on hiswai:

Excerpt

Millennium Management LLC now owns 2,192,158 shares of the biopharmaceutical company's stock valued at $3,464,000 after buying an additional 900,743 ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up